Core Viewpoint - The article highlights the significant rise in the stock price of Huajian Medical (01931.HK), which has surged due to its innovative strategy involving Ethereum reserves and the tokenization of medical assets, positioning it as a unique investment opportunity in the Hong Kong market [2][20]. Group 1: Stock Performance and Market Reaction - Since July, Huajian Medical's stock price has increased by approximately 120% in July and over 91% in August, with a market capitalization exceeding 150 billion HKD [2]. - The company's strategic announcements have been well-received by investors, indicating a strong market expectation for its growth potential [3]. Group 2: Ethereum Reserve Strategy - Huajian Medical has initiated an Ethereum reserve strategy, which includes a plan to continuously increase its Ethereum holdings through various funding sources [2][3]. - The company has already purchased 5,190 Ethereum at a cost of 3,661 USD each, realizing a floating profit of about 3.3 million USD as Ethereum's price surpassed 4,300 USD [3]. Group 3: Market Positioning and Valuation - The company is positioned as a rare asset in the Hong Kong market, combining "crypto asset treasury + healthcare + RWA" (Real World Assets) [4][12]. - The valuation of Huajian Medical is expected to benefit from the rising value of Ethereum, similar to other companies holding significant Ethereum reserves [6][8]. Group 4: Tokenization of Medical Assets - Huajian Medical is actively involved in the tokenization of innovative drug assets, which enhances asset liquidity and allows for easier access to funding [16][17]. - The establishment of the ivd.xyz exchange aims to convert intellectual property related to innovative drugs into tradable tokens, addressing traditional financing challenges in the medical sector [17]. Group 5: Strategic Partnerships and Future Outlook - The company is forming strategic partnerships, such as with HashKey Group, to optimize its Ethereum management and expand its market resources [18]. - The innovative model being developed by Huajian Medical could potentially transform the medical industry by facilitating the digitization and securitization of assets, thereby improving overall efficiency and competitiveness [19].
港股再现新物种！华检医疗飙涨4倍引爆市场